Danusertib Hydrochloride (PHA-739358), a Multi-Kinase Aurora Inhibitor, Elicits Clinical Benefit in Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia .
Jörge E. Cortes(Augusta University Health), Silvia Comis(Nerviano Medical Sciences), Tim H. Brümmendorf(National University Cancer Institute, Singapore), Philippe Schafhausen(University Medical Center Hamburg-Eppendorf), B. Laffranchi(Nerviano Medical Sciences), Nicolas Boissel(Inserm), Hervé Dombret(University of London Institute in Paris), Fabio Latini(Nerviano Medical Sciences), Laura Capolongo(Nerviano Medical Sciences)
Cited by 44
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k